FENC vs NDSN · rev $17.9M vs P/E 31, rev $817.7M
Fennec Pharmaceuticals Inc (FENC) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
FENC currently screens at market cap $302.2M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the FENC and NDSN stock pages for the full models.
Not investment advice.